- Cannabix Technologies (OTC: BLOZF) has started the first production run of BreathLogix alcohol screening devices.
- The production is in collaboration with Price Electronics, an ISO-certified manufacturer with a 28,000 square foot facility in Winnipeg.
- BreathLogix "Workplace Series" device has secured approval from the National Highway Traffic Safety Association and is listed in the U.S. Federal Register Conforming Products List.
Cannabix Technologies Inc. (OTC: BLOZF) has commenced production of its BreathLogix alcohol screening devices in partnership with Price Electronics. The manufacturing is taking place at Price Electronics' 28,000 square foot facility located in Winnipeg, which is equipped with ISO 13485, ISO9001, and IPC certifications. This collaboration ensures scalable production capabilities for the initial commercial run.
The BreathLogix "Workplace Series" device has received approval from the National Highway Traffic Safety Association (NHTSA) and has been added to the U.S. Federal Register Conforming Products List for breath alcohol screening devices. This recognition bolsters the device's market credibility in the United States.
Moreover, Cannabix Technologies has entered into an exclusive distribution agreement with Breathalyser Sales & Service Pty Ltd., covering regions including Australia, New Zealand, and the Pacific Islands. Despite the progress in production and distribution planning, Cannabix is not currently in the phase of selling breathalyzers, and future sales remain uncertain.
These developments are part of Cannabix's strategic efforts to commercialize its breathalyzer technologies, offering a projection of future growth in the medical devices sector. However, investors should note that the company has highlighted potential regulatory and market uncertainties that may affect its forward-looking plans.
